Gara Jalqabaatti › Kansarii Ovarii › Pennsylvania › Philadelphia
Qorannoo klinikaalii Kansarii Ovarii Philadelphia, PA keessatti
Qorannoo 44 Kansarii Ovarii f Philadelphia fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Namoota walitti qabaa jiraSadarkaa 2/3
- Thomas Jefferson University Hospital, Philadelphia
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- fi 4 dabalataa
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Namoota walitti qabaa jira
- University of Pennsylvania, Philadelphia
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Namoota walitti qabaa jiraSadarkaa 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Site 0232 - University of Pennsylvania, Philadelphia
- Site 0178 - Thomas Jefferson University, Philadelphia
Study of AVZO-021 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
DESTINY-PANTUMOUR04
Namoota walitti qabaa jiraQorannoo ilaalaa
- Research Site, Philadelphia
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Namoota walitti qabaa jiraSadarkaa 1/2
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Pennsylvania Hospital, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · Miili 13 fagaatti
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Namoota walitti qabaa jira
- Fox Chase Cancer Center - Philadelphia, Philadelphia
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Pennsylvania, Philadelphia
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Namoota walitti qabaa jiraSadarkaa 3
- Hospital of the University of Pennsylvania ( Site 0071), Philadelphia
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Namoota walitti qabaa jiraSadarkaa 3
- Lankenau Medical Center, Wynnewood · Miili 7 fagaatti
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Namoota walitti qabaa jiraSadarkaa 1
- SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- ACPMP, Springfield · Miili 8 fagaatti
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Namoota walitti qabaa jiraSadarkaa 3
- Site 0109, Philadelphia
- Site 0113, Philadelphia
- Site 0114, Willow Grove · Miili 13 fagaatti
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Namoota walitti qabaa jira
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · Miili 7 fagaatti
- fi 5 dabalataa
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- fi 5 dabalataa
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Namoota walitti qabaa jiraSadarkaa 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Investigative Site #109, Philadelphia
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Namoota walitti qabaa jiraSadarkaa 2
- University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Namoota walitti qabaa jiraSadarkaa 1
- University of Pennsylvania, Philadelphia
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Lankenau Medical Center/Mainline Medical Center, Wynnewood · Miili 7 fagaatti
- Jefferson Abington Hospital, Abington · Miili 12 fagaatti
- Asplundh Cancer Pavilion, Willow Grove · Miili 13 fagaatti
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Namoota walitti qabaa jira
- Hospital of the University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Healthy Volunteers Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Namoota walitti qabaa jiraSadarkaa 2
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Philadelphia
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Gynecologic Oncology Group, Philadelphia
Qorannoo Kansarii Ovarii magaalota biroo keessatti
- Houston, TXQorannoo 89
- New York City, NYQorannoo 69
- Boston, MAQorannoo 61
- Los Angeles, CAQorannoo 50
- Nashville, TNQorannoo 49
- Arlington, VAQorannoo 46
- Columbus, OHQorannoo 39
- St. Louis, MOQorannoo 38
- Chicago, ILQorannoo 36
- San Antonio, TXQorannoo 31
- Cleveland, OHQorannoo 30
- Pittsburgh, PAQorannoo 30
Qorannoo biroo Philadelphia keessatti
- Saree (Gosoota Hunda)Qorannoo 59
- Saree OljooQorannoo 56
- Kansara Qara'a Non-Small CellQorannoo 51
- Kansara MetastatikiiQorannoo 46
- Kansarii ProstateQorannoo 44
- Kansarii ColorectalQorannoo 44
- Dhibee QaraQorannoo 36
- Leukemia Myeloidii HamaaQorannoo 34
- Cufama OnneeQorannoo 31
- Kansa EndometiriyaaliiQorannoo 28
- DepreshiniiQorannoo 26
- Kansarii PancreasQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.